1991PubMedRequires access

An update on home intravenous antibiotic therapy.

Bernstein Lh

Open publisher page 17 citations

Abstract

Home intravenous antibiotic therapy (HIVAT) has proven to be a safe, effective, and cost-saving method to treat appropriately selected patients with bone, soft tissue, respiratory, genitourinary, and cardiac infections. Further, the acceptance of HIVAT by both physicians and patients has been enhanced by the availability of new venous access devices and home IV therapy companies. In determining when to use HIVAT, it is important to carefully consider the individual patient, the disease or medical condition, and antibiotic selection. HIVAT requires a team approach, with the physician, pharmacist, IV therapy nurse, and others playing critical roles in successful treatment plans.

About this research paper

What this paper is about

Home intravenous antibiotic therapy (HIVAT) has proven to be a safe, effective, and cost-saving method to treat appropriately selected patients with bone, soft tissue, respiratory, genitourinary, and cardiac infections. Further, the acceptance of HIVAT by both physicians and patients has been enhanced by the availability of new venous access devices and home IV therapy companies. In determining when to use HIVAT, it is important to carefully consider the individual patient, the disease or medical condition, and antibiotic selection. HIVAT requires a team approach, with the physician, pharmacist, IV therapy nurse, and others playing critical roles in successful treatment plans.

Why it matters

OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Home intravenous antibiotic therapy (HIVAT) has proven to be a safe, effective, and cost-saving method to treat appropriately selected patients with bone, soft tissue, respiratory, genitourinary, and cardiac infections. Further, the acceptance of HIVAT by both physicians and patients has been enhanced by the availability of new venous access devices and home IV therapy companies. In determining when to use HIVAT, it is important to carefully consider the individual patient, the disease or medical condition, and antibiotic selection. HIVAT requires a team approach, with the physician, pharmacist, IV therapy nurse, and others playing critical roles in successful treatment plans.

Key concepts: Medicine, Intravenous therapy, Intensive care medicine, Pharmacist, Antibiotic therapy, Antibiotics, Intravenous antibiotics, Venous access

Related papers

Back to paper searchBrowse research topicsOriginal source
An update on home intravenous antibiotic therapy. — Research Paper | ScholarLens